Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
ACS Infectious Diseases|November 1, 2016
Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetaseStephen Nakazawa Hewitt, David M Dranow, Benjamin G Horst, et al.The Journal of Antimicrobial Chemotherapy|March 4, 2022
Broad-spectrum in vitro activity of macrophage infectivity potentiator inhibitors against Gram-negative bacteria and Leishmania majorJua Iwasaki, Donald D Lorimer, Mirella Vivoli-Vega, et al.Plos One|February 6, 2013
Combining functional and structural genomics to sample the essential Burkholderia structomeLoren Baugh, Larry A Gallagher, Rapatbhorn Patrapuvich, et al.Plos One|March 24, 2021
Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoebaLogan Tillery, Kayleigh Barrett, Jenna Goldstein, et al.Journal of Medicinal Chemistry|November 10, 2017
Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH)Ganesha Rai, Kyle R Brimacombe, Bryan T Mott, et al.Tuberculosis (Edinburgh, Scotland)|January 24, 2015
Increasing the structural coverage of tuberculosis drug targetsLoren Baugh, Isabelle Phan, Darren W Begley, et al.Communications Biology|December 5, 2024
Exquisite selectivity of griselimycin extends to beta subunit of DNA polymerases from Gram-negative bacterial pathogensMichael K Fenwick, Phillip G Pierce, Jan Abendroth, et al.Journal of Medicinal Chemistry|September 9, 2020
Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic PropertiesGanesha Rai, Daniel J Urban, Bryan T Mott, et al.Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.Pageof 4